October 4, 2016 -
Valencell was among a select group of technology and consumer electronics companies invited to exhibit at last week’s Digital Health Technology Expo, sponsored by the U.S. Food and Drug Administration (FDA) and the Consumer Technology Association (CTA) and held at the FDA’s headquarters in Silver Spring, Maryland.
Valencell demonstrated its biometric sensor technology and its ability to accurately measure RR-interval in wearable devices worn in numerous form-factors.
The Expo also featured presentations from the CTA, FDA, the U.S. Department of Health and Human Services, as well as other government, academic and industry market leaders on consumer technology’s critical role in advancing healthcare. Sessions discussed innovations in biometric wearables for healthcare data delivery; ways in which innovators and regulators can work collaboratively to drive innovation in healthcare technology, and; how patient generated data can create positive change in healthcare delivery through empowering patients and caregivers to drive positive behavior change and reduce health risks, leading to better treatment and outcomes.
“We are honored to be invited by the CTA and FDA to participate in this event, and to have the opportunity to showcase some of our latest innovations in biometric data sensor technology for health applications, including accurate continuous RR-interval monitoring technology that can ultimately be used for important health screening applications and fitness assessments,” said Dr. Steven LeBoeuf, president and co-founder of Valencell. “The goal of Valencell’s innovation in wearable technology is to make biometric monitoring easy, affordable, and seamless with everyday living, so that more accurate data can be taken frequently enough to drive personalized health insights and guidance. We look forward to working with government and industry groups, and our partners, to help drive continued growth in this market.”
Other companies that exhibited included Philips, Qualcomm, Sony, Samsung, Fossil/Misfit and Validic.